Yes, Trump did tell RFK Jr. to investigate vaccine dangers—and why it matters by Jon Rappoport for No More Fake News
In this explosive 12 minute Theo Von video interview with Robert Kennedy Jr. [1], we get details of the 2016 Trump-Kennedy meeting, at which Trump gave Kennedy the go-ahead to investigate vaccine dangers.
This isn’t simply “setting the record straight” on what went down. The latest official figures on autism? 1 in 54 American children are autistic. So we are talking about the MASSIVE destruction of life, and the ongoing internal destruction of the country.
Investigating and detailing the role vaccines play in this horrific reality should be the highest priority.
Now is your chance to support Gospel News Network.
We love helping others and believe that’s one of the reasons we are chosen as Ambassadors of the Kingdom, to serve God’s children. We look to the Greatest Commandment as our Powering force.
Robert Kennedy, in the video interview, explains that shortly after Trump was elected in November of 2016, the new president contacted him (Kennedy) and invited him for a meeting at Trump Tower in New York.
During the two-hour sit-down with Trump, Kennedy explained that a comprehensive investigation of vaccines could be done without any heavy lifting by government. There was a well-known Vaccine Safety Datalink [2] [2b] [2c] [2d] which, when opened, would give independent researchers access to a vast trove of US medical records. From those records, a convincing case could be made about vaccine safety/dangers.
Trump gave Kennedy the green light to move ahead.
However, roadblocks then appeared.
Access to the Vaccine Safety Datalink and the medical records was severely limited. Two independent investigators were confined to one room—with only pencil and paper—to study medical records. The room was intentionally overheated to a temperature of 105. No copying-machine use was permitted.
Then Pfizer made a million-dollar contribution to Trump’s inauguration.
Then Trump made two grotesque appointments to his new administration—Scott Gottlieb as FDA commissioner, and Alex Azar as head of Health and Human Services. Both men had heavy pharmaceutical industry connections. Azar had served as chief of US Eli Lilly, and had sat on the board of the pharma trade group, the Biotechnology Innovation Organization. Scott Gottlieb was a director at Tolero Pharmaceuticals and the giant drug company, Daiichi Sankyo. He also worked for Glaxo; and now, in 2021, after his stint as FDA commissioner, Gottlieb sits on the board of Pfizer.
